142 related articles for article (PubMed ID: 22247351)
1. IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis.
Troelsen LN; Jacobsen S; Abrahams JL; Royle L; Rudd PM; Narvestad E; Heegaard NH; Garred P
J Rheumatol; 2012 Mar; 39(3):463-9. PubMed ID: 22247351
[TBL] [Abstract][Full Text] [Related]
2. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?
Troelsen LN; Garred P; Jacobsen S
J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521
[TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis.
Jacobsen S; Garred P; Madsen HO; Heegaard NH; Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Smedegaard Andersen L; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Vestergaard A; Østergaard M; Hørslev-Petersen K
J Rheumatol; 2009 Apr; 36(4):731-5. PubMed ID: 19273450
[TBL] [Abstract][Full Text] [Related]
4. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
[TBL] [Abstract][Full Text] [Related]
5. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis.
Troelsen LN; Garred P; Madsen HO; Jacobsen S
Arthritis Rheum; 2007 Jan; 56(1):21-9. PubMed ID: 17195187
[TBL] [Abstract][Full Text] [Related]
6. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
7. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever.
Schafranski MD; Pereira Ferrari L; Scherner D; Torres R; Jensenius JC; de Messias-Reason IJ
Mol Immunol; 2008 Aug; 45(14):3827-31. PubMed ID: 18602696
[TBL] [Abstract][Full Text] [Related]
8. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
[TBL] [Abstract][Full Text] [Related]
9. Association of variant alleles of MBL2 gene with vasoocclusive crisis in children with sickle cell anemia.
Mendonça TF; Oliveira MC; Vasconcelos LR; Pereira LM; Moura P; Bezerra MA; Santos MN; Araújo AS; Cavalcanti MS
Blood Cells Mol Dis; 2010 Apr; 44(4):224-8. PubMed ID: 20172753
[TBL] [Abstract][Full Text] [Related]
10. Structural polymorphisms in the mannose-binding lectin gene are associated with juvenile idiopathic arthritis.
Gergely P; Pazár B; Nagy ZB; Gombos T; Rajczy K; Balogh Z; Orbán I; Sevcic K; Poór G
J Rheumatol; 2009 Apr; 36(4):843-7. PubMed ID: 19286845
[TBL] [Abstract][Full Text] [Related]
11. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.
Lard LR; van Gaalen FA; Schonkeren JJ; Pieterman EJ; Stoeken G; Vos K; Nelissen RG; Westendorp RG; Hoeben RC; Breedveld FC; Toes RE; Huizinga TW
Arthritis Rheum; 2003 Jul; 48(7):1841-8. PubMed ID: 12847677
[TBL] [Abstract][Full Text] [Related]
12. Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis.
Maury CP; Aittoniemi J; Tiitinen S; Laiho K; Kaarela K; Hurme M
J Intern Med; 2007 Oct; 262(4):466-9. PubMed ID: 17875183
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
Ingegnoli F; Fantini F; Favalli EG; Soldi A; Griffini S; Galbiati V; Meroni PL; Cugno M
J Autoimmun; 2008 Sep; 31(2):175-9. PubMed ID: 18707846
[TBL] [Abstract][Full Text] [Related]
14. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis.
Ercan A; Cui J; Hazen MM; Batliwalla F; Royle L; Rudd PM; Coblyn JS; Shadick N; Weinblatt ME; Gregersen P; Lee DM; Nigrovic PA
Arthritis Res Ther; 2012 Mar; 14(2):R43. PubMed ID: 22390545
[TBL] [Abstract][Full Text] [Related]
15. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.
Brown DA; Moore J; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN
Arthritis Rheum; 2007 Mar; 56(3):753-64. PubMed ID: 17328047
[TBL] [Abstract][Full Text] [Related]
16. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
Lard LR; Roep BO; Toes RE; Huizinga TW
J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
[TBL] [Abstract][Full Text] [Related]
20. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis.
Popa C; Netea MG; Radstake TR; van Riel PL; Barrera P; van der Meer JW
Ann Rheum Dis; 2005 Aug; 64(8):1195-8. PubMed ID: 15731289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
